NanoMaterials Technology Signs Exclusive Licensing Agreement for Hyperlipidemia-controlling Drug with Beijing Winsunny Pharmaceutical

By Nanomaterials Technology Pte Ltd, PRNE
Wednesday, April 7, 2010

SINGAPORE, April 8, 2010 - NanoMaterials Technology Private Limited ("NMT") announced today that it
has signed an exclusive licensing agreement with Beijing Winsunny
Pharmaceutical Company Limited ("Winsunny Pharma") for the use of its
proprietary High Gravity Controlled Precipitation ("HGCP") Technology to
manufacture, market and distribute a generic version of a world-wide
blockbuster hyperlipidemia-controlling drug in China with a potential market
size of over US$900 million. Currently, there are 90 million patients in
China undergoing long-term treatment for hyperlipidemia. The annual growth
rate of the patients is about 15 million and it is estimated that the number
of patients required the treatment will reach 200 million in the next 10
years.

Under the terms of the agreement, Winsunny Pharma will pay an undisclosed
upfront fee as well as milestones and royalty payments based on future sales
of the drug. NMT will provide a new formulation that will increase efficacy,
lower drug dosage and provide better patient compliance. Winsunny Pharma will
assume all the costs of development, regulatory and commercialization of the
solid oral dosage formed drug including clinical trials.

"Today's announcement is an important milestone for NMT in deploying our
HGCP technology in one of the fastest growing and most important markets in
the world for the pharmaceutical sector," said Dr. Jimmy Yun, CEO of NMT.
"Previously, we had demonstrated the use of HGCP Technology in mass
production of specialty chemicals. This is our first collaboration with
Winsunny Pharma and it provides an opportunity to extend the product range of
their hyperlipidemia-controlling drugs. We believe that this is the beginning
of a series of drugs using our technology to be made available in the market.
We look forward to having more collaboration with Winsunny Pharma in future."

"We have various late stage developments which have the potential to
reach commercialization in the near future. Currently, we are in talks with
pharmaceutical companies in the US, Europe and China to commercialise several
compounds using HGCP technology," continued Dr. Yun.

The HGCP Technology allows production of active pharmaceutical ingredient
("API") at both low micron and nano-sized range. NMT has demonstrated the
suitability of the technology for processing APIs of both small and macro
molecules to be formulated for solid oral dosage and inhalation forms. The
HGCP Technology is also being used for designing drug particles with good
aerodynamic properties and specific particle size distribution for pulmonary
inhalation. It consolidates the current conventional "crystallization,
micronization and conditioning" manufacturing processes into one-step, which
is cost and time-saving.

About NanoMaterials Technology Pte Ltd (www.nanomt.com)

Founded in April 2000, NanoMaterials Technology (NMT) is a Singapore
company that specialises in the development and commercialisation of the
production technologies of nano-materials. NMT has a proprietary technology
called the High Gravity Controlled Precipitation (HGCP). The result of this
breakthrough is a nano-material production technology that is simple, easy to
scale up and extremely cost effective. The HGCP Technology is versatile to be
coupled with NMT's dispersion technology and know how to improve the
dispersibility of the nano-particles.

About Beijing Winsunny Pharmaceutical Co., Ltd. (www.bjwsyy.com)

Founded in February 1999, Winsunny Pharma is a pharmaceutical company in
Beijing and is a subsidiary of Zhejiang NHU Group (www.cnhu.com/en).
Zhejiang NHU Group is a public-listed company in Shenzhen Stock Exchange,
China. Winsunny Pharma specializes in hyperlipidemia-controlling, high blood
pressure, nephrology, CNS and diabetes drugs.

    Contact Details:
    NanoMaterials Technology Pte Ltd
    Ms. Grace Yeo
    Tel: +65-6873-0735
    Email: grace.yeo@nanomt.com

Ms. Grace Yeo of NanoMaterials Technology Pte Ltd, +65-6873-0735, or grace.yeo at nanomt.com

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :